(Q48427115)

11 February 2018

title

Neuroprotective effects of YM872 coadministered with t-PA in a rat embolic stroke model. (English)

1 reference

11 February 2018

1 reference

Masanori Suzuki

1

1 reference

11 February 2018

Masao Sasamata

series ordinal

2

1 reference

11 February 2018

Keiji Miyata

series ordinal

3

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 January 2003

1 reference

11 February 2018

published in

Brain Research

1 reference

11 February 2018

volume

959

1 reference

11 February 2018

issue

1

1 reference

11 February 2018

page(s)

169-172

1 reference

11 February 2018

Recommendations for standards regarding preclinical neuroprotective and restorative drug development

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903759-9

Neuroprotection with NBQX and thrombolysis with rt-PA in rat embolic stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903759-9

In-vitro characterization of YM872, a selective, potent and highly water-soluble alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903759-9

Neuroprotective effects of an AMPA receptor antagonist YM872 in a rat transient middle cerebral artery occlusion model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903759-9

A novel AMPA receptor antagonist, YM872, reduces infarct size after middle cerebral artery occlusion in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903759-9

YM872, a highly water-soluble AMPA receptor antagonist, preserves the hemodynamic penumbra and reduces brain injury after permanent focal ischemia in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903759-9

Neuroprotective effect of the novel glutamate AMPA receptor antagonist YM872 assessed with in vivo MR imaging of rat MCA occlusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903759-9

An animal model of cerebral infarction. Homologous blood clot emboli in rats.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903759-9

Hemorrhagic transformation after fibrinolytic therapy with tissue plasminogen activator in a rat thromboembolic model of stroke

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903759-9

Effects of tissue type plasminogen activator in embolic versus mechanical models of focal cerebral ischemia in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903759-9

Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903759-9

Early complete recanalization in internal carotid artery embolism treated with high-dose t-PA: a sequential angiographic study in a novel model of embolism in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903759-9

Enhancing the efficacy of thrombolysis by AMPA receptor blockade with NBQX in a rat embolic stroke model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2802%2903759-9

10.1016/S0006-8993(02)03759-9

7 January 2021

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018